| Application no. and date | 08834136.7 (espacenet) (Federated) (European Patent Register), 20080926 | | Patent/reg. no. and date | DK/EP 2193196, 20160713 | | Publication date | 20100609 | | Priority no. and date | US 976343 P, 20070928, US 90574 P, 20080820 | | EP pub. no. and date |
EP 2193196 20100609 | | Effective date | | | Applicant/owner | Alexion Pharmaceuticals, Inc., 121 Seaport Boulevard
Boston, MA 02210, US | | Applicant ref. no. | PORTOLA EP2193196 | | Inventor | LU, Genmin, 1439 El Camino Real Apt. 9
Burlingame
California 94010, US,
PHILLIPS, David R., 520 Harvard Road
San Mateo
California 94402, US,
ANDRE, Patrick, 950 N. Humboldt Street
San Mateo
California 94401, US,
SINHA, Uma, 808 Junipero Serra Boulevard
San Francisco
California 94127, US | | Representative | | | Opponent | | | IPC Class | A61K 38/48 (2006.01) , A61P 7/04 (2006.01) , C12N 9/64 (2006.01) | | Title | ANTIDOTER MOD FAKTOR XA-INHIBITORER OG FREMGANGSMÅDER TIL ANVENDELSE DERAF | | Int. application no. | US2008078014 | | Int. publication no. | WO2009042962 | | Related patent (certificate) | CA 2019 00053 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
